[96a5a0]: / output / allTrials / identified / NCT00842829_identified.json

Download this file

491 lines (491 with data), 22.9 kB

  1
  2
  3
  4
  5
  6
  7
  8
  9
 10
 11
 12
 13
 14
 15
 16
 17
 18
 19
 20
 21
 22
 23
 24
 25
 26
 27
 28
 29
 30
 31
 32
 33
 34
 35
 36
 37
 38
 39
 40
 41
 42
 43
 44
 45
 46
 47
 48
 49
 50
 51
 52
 53
 54
 55
 56
 57
 58
 59
 60
 61
 62
 63
 64
 65
 66
 67
 68
 69
 70
 71
 72
 73
 74
 75
 76
 77
 78
 79
 80
 81
 82
 83
 84
 85
 86
 87
 88
 89
 90
 91
 92
 93
 94
 95
 96
 97
 98
 99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
287
288
289
290
291
292
293
294
295
296
297
298
299
300
301
302
303
304
305
306
307
308
309
310
311
312
313
314
315
316
317
318
319
320
321
322
323
324
325
326
327
328
329
330
331
332
333
334
335
336
337
338
339
340
341
342
343
344
345
346
347
348
349
350
351
352
353
354
355
356
357
358
359
360
361
362
363
364
365
366
367
368
369
370
371
372
373
374
375
376
377
378
379
380
381
382
383
384
385
386
387
388
389
390
391
392
393
394
395
396
397
398
399
400
401
402
403
404
405
406
407
408
409
410
411
412
413
414
415
416
417
418
419
420
421
422
423
424
425
426
427
428
429
430
431
432
433
434
435
436
437
438
439
440
441
442
443
444
445
446
447
448
449
450
451
452
453
454
455
456
457
458
459
460
461
462
463
464
465
466
467
468
469
470
471
472
473
474
475
476
477
478
479
480
481
482
483
484
485
486
487
488
489
490
491
{
"info": {
"nct_id": "NCT00842829",
"official_title": "A European Multicenter Open-Label Study of Breakthrough Cancer Pain: Assessment of Fentanyl Buccal Tablets Titration and Treatment in Opioid-Tolerant Patients",
"inclusion_criteria": "* The patient is willing to provide written informed consent to participate in this study.\n* The patient can be either an out-patient or an in-patient.\n* The patient has a histologically documented diagnosis of cancer.\n* The patient has stable background pain due to cancer.\n* The patient experiences up to 4 BTcP episodes per 24 hours.\n* As maintenance opioid therapy, the patient is currently taking 1 of the following: at least 60 mg of oral morphine/day, at least 25 mcg of transdermal fentanyl/hour, at least 30 mg of oxycodone/day, at least 8 mg of hydromorphone/day, of an equianalgesic dose of another opioid for a week or longer before administration of the first dose of study drug.\n* Women of childbearing potential, using a medically accepted, highly effective method of birth control and agree to continued use of this method for the duration of the study.\n* The patient must be willing and able to successfully self-administer the study drug and to fill in study documents.\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
"exclusion_criteria": "* The patient is without maintenance opioid therapy.\n* The patient has uncontrolled or rapidly escalating pain as determined by the investigator.\n* The patient has known or suspected hypersensitivities, allergies, or other contraindications to the active drug or to any of the excipients of the study drug.\n* The patient has respiratory depression or chronic obstructive pulmonary disease, or any other medical condition predisposing to respiratory depression.\n* The patient has medical or psychiatric disease that, in the opinion of the investigator, would compromise collected data.\n* The patient is expected to have surgery during the study.\n* The patient is pregnant or lactating.\n* The patient has participated in a study involving an investigational drug in the prior 30 days.\n* The patient has received a monoamine oxidase inhibitor (MAOI) within 14 days before the first treatment with study drug.\n* The patient has any other medical condition or is receiving concomitant medication/therapy (e.g., regional nerve block) that could, in the opinion of the investigator, compromise the patient's safety or compliance with the study protocol, or compromise collected data.",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"line": "* The patient is willing to provide written informed consent to participate in this study.",
"criterions": [
{
"exact_snippets": "willing to provide written informed consent",
"criterion": "informed consent",
"requirements": [
{
"requirement_type": "willingness",
"expected_value": true
}
]
}
]
},
{
"line": "* The patient can be either an out-patient or an in-patient.",
"criterions": [
{
"exact_snippets": "The patient can be either an out-patient or an in-patient.",
"criterion": "patient status",
"requirements": [
{
"requirement_type": "status",
"expected_value": [
"out-patient",
"in-patient"
]
}
]
}
]
},
{
"line": "* The patient has a histologically documented diagnosis of cancer.",
"criterions": [
{
"exact_snippets": "histologically documented diagnosis of cancer",
"criterion": "cancer diagnosis",
"requirements": [
{
"requirement_type": "documentation",
"expected_value": "histologically"
}
]
}
]
},
{
"line": "* The patient has stable background pain due to cancer.",
"criterions": [
{
"exact_snippets": "stable background pain due to cancer",
"criterion": "background pain",
"requirements": [
{
"requirement_type": "stability",
"expected_value": "stable"
},
{
"requirement_type": "cause",
"expected_value": "cancer"
}
]
}
]
},
{
"line": "* The patient experiences up to 4 BTcP episodes per 24 hours.",
"criterions": [
{
"exact_snippets": "up to 4 BTcP episodes per 24 hours",
"criterion": "BTcP episodes",
"requirements": [
{
"requirement_type": "frequency",
"expected_value": {
"operator": "<=",
"value": 4,
"unit": "episodes per 24 hours"
}
}
]
}
]
},
{
"line": "* As maintenance opioid therapy, the patient is currently taking 1 of the following: at least 60 mg of oral morphine/day, at least 25 mcg of transdermal fentanyl/hour, at least 30 mg of oxycodone/day, at least 8 mg of hydromorphone/day, of an equianalgesic dose of another opioid for a week or longer before administration of the first dose of study drug.",
"criterions": [
{
"exact_snippets": "As maintenance opioid therapy, the patient is currently taking 1 of the following: at least 60 mg of oral morphine/day",
"criterion": "oral morphine",
"requirements": [
{
"requirement_type": "dosage",
"expected_value": {
"operator": ">=",
"value": 60,
"unit": "mg/day"
}
}
]
},
{
"exact_snippets": "As maintenance opioid therapy, the patient is currently taking 1 of the following: ... at least 25 mcg of transdermal fentanyl/hour",
"criterion": "transdermal fentanyl",
"requirements": [
{
"requirement_type": "dosage",
"expected_value": {
"operator": ">=",
"value": 25,
"unit": "mcg/hour"
}
}
]
},
{
"exact_snippets": "As maintenance opioid therapy, the patient is currently taking 1 of the following: ... at least 30 mg of oxycodone/day",
"criterion": "oxycodone",
"requirements": [
{
"requirement_type": "dosage",
"expected_value": {
"operator": ">=",
"value": 30,
"unit": "mg/day"
}
}
]
},
{
"exact_snippets": "As maintenance opioid therapy, the patient is currently taking 1 of the following: ... at least 8 mg of hydromorphone/day",
"criterion": "hydromorphone",
"requirements": [
{
"requirement_type": "dosage",
"expected_value": {
"operator": ">=",
"value": 8,
"unit": "mg/day"
}
}
]
},
{
"exact_snippets": "As maintenance opioid therapy, the patient is currently taking 1 of the following: ... of an equianalgesic dose of another opioid for a week or longer before administration of the first dose of study drug.",
"criterion": "equianalgesic dose of another opioid",
"requirements": [
{
"requirement_type": "duration",
"expected_value": "a week or longer"
}
]
}
]
},
{
"line": "* Women of childbearing potential, using a medically accepted, highly effective method of birth control and agree to continued use of this method for the duration of the study.",
"criterions": [
{
"exact_snippets": "Women of childbearing potential",
"criterion": "childbearing potential",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "using a medically accepted, highly effective method of birth control",
"criterion": "birth control method",
"requirements": [
{
"requirement_type": "effectiveness",
"expected_value": "highly effective"
},
{
"requirement_type": "acceptance",
"expected_value": "medically accepted"
}
]
},
{
"exact_snippets": "agree to continued use of this method for the duration of the study",
"criterion": "birth control method usage",
"requirements": [
{
"requirement_type": "duration",
"expected_value": "for the duration of the study"
}
]
}
]
},
{
"line": "* The patient must be willing and able to successfully self-administer the study drug and to fill in study documents.",
"criterions": [
{
"exact_snippets": "willing and able to successfully self-administer the study drug",
"criterion": "self-administration of study drug",
"requirements": [
{
"requirement_type": "willingness",
"expected_value": true
},
{
"requirement_type": "ability",
"expected_value": true
}
]
},
{
"exact_snippets": "willing and able ... to fill in study documents",
"criterion": "completion of study documents",
"requirements": [
{
"requirement_type": "willingness",
"expected_value": true
},
{
"requirement_type": "ability",
"expected_value": true
}
]
}
]
},
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "healthy"
}
]
}
]
},
{
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
]
}
]
}
],
"exclusion_lines": [
{
"line": "* The patient is without maintenance opioid therapy.",
"criterions": [
{
"exact_snippets": "without maintenance opioid therapy",
"criterion": "maintenance opioid therapy",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
},
{
"line": "* The patient has uncontrolled or rapidly escalating pain as determined by the investigator.",
"criterions": [
{
"exact_snippets": "uncontrolled or rapidly escalating pain",
"criterion": "pain",
"requirements": [
{
"requirement_type": "severity",
"expected_value": [
"uncontrolled",
"rapidly escalating"
]
}
]
}
]
},
{
"line": "* The patient has known or suspected hypersensitivities, allergies, or other contraindications to the active drug or to any of the excipients of the study drug.",
"criterions": [
{
"exact_snippets": "known or suspected hypersensitivities, allergies, or other contraindications to the active drug",
"criterion": "hypersensitivities, allergies, or contraindications to the active drug",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "known or suspected hypersensitivities, allergies, or other contraindications ... to any of the excipients of the study drug",
"criterion": "hypersensitivities, allergies, or contraindications to excipients of the study drug",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* The patient has respiratory depression or chronic obstructive pulmonary disease, or any other medical condition predisposing to respiratory depression.",
"criterions": [
{
"exact_snippets": "The patient has respiratory depression",
"criterion": "respiratory depression",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "chronic obstructive pulmonary disease",
"criterion": "chronic obstructive pulmonary disease",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "any other medical condition predisposing to respiratory depression",
"criterion": "medical condition predisposing to respiratory depression",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* The patient has medical or psychiatric disease that, in the opinion of the investigator, would compromise collected data.",
"criterions": [
{
"exact_snippets": "medical or psychiatric disease",
"criterion": "medical or psychiatric disease",
"requirements": [
{
"requirement_type": "impact on data",
"expected_value": "compromise collected data"
}
]
}
]
},
{
"line": "* The patient is expected to have surgery during the study.",
"criterions": [
{
"exact_snippets": "The patient is expected to have surgery during the study.",
"criterion": "surgery",
"requirements": [
{
"requirement_type": "timing",
"expected_value": "during the study"
}
]
}
]
},
{
"line": "* The patient is pregnant or lactating.",
"criterions": [
{
"exact_snippets": "The patient is pregnant",
"criterion": "pregnancy",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "lactating",
"criterion": "lactation",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* The patient has participated in a study involving an investigational drug in the prior 30 days.",
"criterions": [
{
"exact_snippets": "The patient has participated in a study involving an investigational drug in the prior 30 days.",
"criterion": "participation in a study involving an investigational drug",
"requirements": [
{
"requirement_type": "time frame",
"expected_value": {
"operator": "<=",
"value": 30,
"unit": "days"
}
}
]
}
]
},
{
"line": "* The patient has received a monoamine oxidase inhibitor (MAOI) within 14 days before the first treatment with study drug.",
"criterions": [
{
"exact_snippets": "The patient has received a monoamine oxidase inhibitor (MAOI) within 14 days before the first treatment with study drug.",
"criterion": "monoamine oxidase inhibitor (MAOI)",
"requirements": [
{
"requirement_type": "time since last dose",
"expected_value": {
"operator": "<=",
"value": 14,
"unit": "days"
}
}
]
}
]
},
{
"line": "* The patient has any other medical condition or is receiving concomitant medication/therapy (e.g., regional nerve block) that could, in the opinion of the investigator, compromise the patient's safety or compliance with the study protocol, or compromise collected data.",
"criterions": [
{
"exact_snippets": "The patient has any other medical condition",
"criterion": "other medical condition",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "is receiving concomitant medication/therapy",
"criterion": "concomitant medication/therapy",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
}
],
"miscellaneous_lines": [],
"failed_inclusion": [],
"failed_exclusion": [],
"failed_miscellaneous": []
}